Opko Health, Inc. financial data

Symbol
OPK on Nasdaq
Industry
Pharmaceutical Preparations
Location
4400 Biscayne Blvd., Miami, Florida
State of incorporation
Delaware
Fiscal year end
December 31
Former names
EXEGENICS INC (to 6/13/2007), eXegenics Inc (to 6/13/2007), CYTOCLONAL PHARMACEUTICS INC /DE (to 6/4/2001)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 179 % -3.58%
Quick Ratio 32.2 % -2.75%
Debt-to-equity 45.9 % +20%
Return On Equity -18 % -163%
Return On Assets -12.3 % +5.6%
Operating Margin -24.8 % -22.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 697 M shares -9.79%
Entity Public Float 904 M USD -14.8%
Common Stock, Value, Issued 7.27 M USD -6.96%
Weighted Average Number of Shares Outstanding, Basic 707 M shares -5.94%
Weighted Average Number of Shares Outstanding, Diluted 752 M shares +13.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 800 M USD -12.4%
Research and Development Expense 78.9 M USD -10.5%
Operating Income (Loss) -198 M USD -7.31%
Nonoperating Income (Expense) -52.6 M USD +64.3%
Income Tax Expense (Benefit) 1.85 M USD -209%
Net Income (Loss) Attributable to Parent -252 M USD +13.3%
Earnings Per Share, Basic -0.35 USD/shares +7.9%
Earnings Per Share, Diluted -0.38 USD/shares -111%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 75.6 M USD -31.8%
Accounts Receivable, after Allowance for Credit Loss, Current 111 M USD -8.33%
Inventory, Net 59.4 M USD -21.3%
Other Assets, Current 6.63 M USD +8.96%
Assets, Current 391 M USD -3.72%
Property, Plant and Equipment, Net 64.2 M USD
Operating Lease, Right-of-Use Asset 63.3 M USD +71.9%
Intangible Assets, Net (Excluding Goodwill) 680 M USD
Goodwill 531 M USD -11.2%
Other Assets, Noncurrent 8.58 M USD +2.85%
Assets 1.97 B USD -9.02%
Accounts Payable, Current 71.2 M USD -11.6%
Accrued Liabilities, Current 88.8 M USD -16.3%
Contract with Customer, Liability, Current 0 USD
Liabilities, Current 204 M USD -8.13%
Contract with Customer, Liability, Noncurrent 7 K USD -95%
Deferred Income Tax Liabilities, Net 122 M USD -6.2%
Operating Lease, Liability, Noncurrent 50.9 M USD +92.5%
Other Liabilities, Noncurrent 21.2 M USD -24.2%
Liabilities 721 M USD +16.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -45.2 M USD -20.2%
Retained Earnings (Accumulated Deficit) -2.09 B USD -13.7%
Stockholders' Equity Attributable to Parent 1.25 B USD -19.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.55 B USD -3.91%
Liabilities and Equity 1.97 B USD -9.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.6 M USD -57%
Net Cash Provided by (Used in) Financing Activities 20.6 M USD
Net Cash Provided by (Used in) Investing Activities -4.4 M USD +43%
Common Stock, Shares Authorized 1 B shares 0%
Common Stock, Shares, Issued 727 M shares -6.98%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2 M USD +52.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 75.6 M USD -31.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.13 M USD -18.4%
Deferred Tax Assets, Valuation Allowance 295 M USD +5.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 282 M USD +6.56%
Operating Lease, Liability 62.7 M USD +65.1%
Depreciation 18.7 M USD -6.97%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -260 M USD +12.6%
Lessee, Operating Lease, Liability, to be Paid 76.5 M USD +78.6%
Operating Lease, Liability, Current 11.7 M USD +2.19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.2 M USD +93.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.1 M USD +30.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +22.2%
Deferred Income Tax Expense (Benefit) -2.68 M USD -2727%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.8 M USD +183%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.1 M USD +151%
Deferred Federal Income Tax Expense (Benefit) 52 K USD
Current Income Tax Expense (Benefit) 4.29 M USD -60.7%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 16.9 M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.96 M USD +158%
Operating Lease, Payments 4.33 M USD +11.9%
Additional Paid in Capital 3.39 B USD -1.12%
Current State and Local Tax Expense (Benefit) -946 K USD -340%
Current Federal Tax Expense (Benefit) 487 K USD
Amortization of Intangible Assets 86 M USD -1.42%
Depreciation, Depletion and Amortization 105 M USD -2.44%
Share-based Payment Arrangement, Expense 11.4 M USD -38.4%
Deferred State and Local Income Tax Expense (Benefit) -298 K USD +97.5%
Interest Expense 17.8 M USD +127%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%